Latest News & Features
Africa
Worldwide applications for pharmaceutical patents “peaked sharply” in 2014, reaching around 28,000, a report has shown. 4 August 2015
Americas
A Brazilian court has confirmed that a eucalyptus breed produced by biotechnology company Eldorado Brasil Celulose is genetically identical to pulp producer Fibria Celulose’s own cultivar product VTO2. 4 August 2015
Americas
Pharmaceutical company Celgene has requested that the US Patent and Trademark Office sanctions hedge fund manager Kyle Bass and his company the Coalition for Affordable Drugs, arguing that the inter partes review petitions he has filed are “abusive” and a “tool to affect the stock prices of public companies”. 31 July 2015
Americas
TWi Pharmaceuticals has released a generic version of the Megace ES drug, which is used to treat certain symptoms experienced by AIDS patients, just one day after a court ruled that it did not infringe a patent owned by Par Pharmaceutical. 30 July 2015
Americas
On July 21 the US Court of Appeals for the Federal Circuit ruled in Amgen v Sandoz that biosimilar applicants can opt out of the ‘patent dance’. Courtenay Brinckerhoff of Foley & Lardner considers the decision’s implications for the biosimilars framework and highlights the questions that remain unanswered. 30 July 2015
Americas
Middle Eastern pharmaceutical company Hikma Pharmaceuticals has agreed to buy Roxane Laboratories from Boehringer Ingelheim for $2.65 billion. 30 July 2015
Big Pharma
Bayer has claimed victory after a US district court ruled that a generic version of one of its skin treatment drugs proposed by Glenmark Pharmaceuticals infringed its patent. 28 July 2015
Americas
Medical device manufacturer Medtronic has asked the US Supreme Court to vacate a lower court ruling that it indirectly infringed a patent covering a machine used during spinal surgery, citing the latest ruling in Commil USA v Cisco Systems. 28 July 2015
Asia
Pharmaceutical company Teva has bought Allergan Generics from drugs business Allergan in a $40.5 billion deal. 27 July 2015
Americas
Biotechnology company United Therapeutics has sued Watson Laboratories claiming it has infringed three of its patents covering one of its hypertension treatment drugs. 24 July 2015